ArticleFrontiers in immunology2021

Case Report: High Doses of Intravenous Immunoglobulins as a Successful Treatment for Late Onset Immune Agranulocytosis After Rituximab Plus Bendamustine.

Ramon Diez-Feijóo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.